Limitations of rapid tranquillisation trial.
Jhirwal
O P
OP
Kulhara
P
P
Basu
D
D
D014150:Antipsychotic Agents / Q000627:therapeutic use; D002492:Central Nervous System Depressants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D011398:Promethazine / Q000627:therapeutic use; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D006993:Hypnotics and Sedatives; D011398:Promethazine; D006220:Haloperidol; D008140:Lorazepam